Click Here to Register »

2017 Executive Sponsors

ICON
Mapi
Parexel

2017 Associate Sponsors

Be the Partner
goBalto
PRA
PSI
QUINTILES IMS
Verified Clinical Trials
Veristat

2017 Supporting Sponsor

monARC Bionetworks

2017 Exhibitors

Altasciences
Cmed
DaVita Clinical Research
InSeption Group
RxSolutions
Stirling Ultracold

2017 Lead Media Partner

CenterWatch

2017 Supporting Partner

Greater Gift Initiative

2017 Media Partners

Big3Bio
BioPharm Insight
BioPharma Dive
CanBiotech
Clinical Leader
Life Science Leader
MNT
Pharmaceutical Online
Pharmalicensing
Pharmaphorum
PharmaVOICE
Rebar Interactive
SciDoc Publishers
Technology Networks

  • March 20, 2017

  • Takeda Pharmaceutical Company and PRA Health Sciences will Jointly Present at CTC

    PRA Health Sciences, Inc. and Takeda Pharmaceutical Company announced in September that the companies have entered into a new partnership agreement under which PRA will serve as Takeda’s primary strategic partner to deliver on the company’s pipeline and marketed products clinical development and post-approval needs. “This partnership is a fundamental part of Takeda’s R&D transformation […]

    PRA Health Sciences, Inc. and Takeda Pharmaceutical Company announced in September that the companies have entered into a new partnership agreement under which PRA will serve as Takeda’s primary strategic partner to deliver on the company’s pipeline and marketed products clinical development and post-approval needs.

    “This partnership is a fundamental part of Takeda’s R&D transformation and represents a truly innovative approach to clinical development, unprecedented in our industry,” said Andy Plump, MD, PhD, Director, Chief Medical and Scientific Officer at Takeda.

    The idea of the partnership is to provide a flexible operating model that combines operational expertise, transferred from Takeda to PRA. This model is aimed to improve operating efficiencies and provide a flexible approach to facilitate the development of new medicines by focusing resources, teams and activities where needed.

    On April 3rd at the CTC conference, both Andy Plump, MD, PhD, Chief Medical and Scientific Officer, Takeda and Tami Klerr, EVP, Business Development, PRA Health Sciences will jointly present an update on how their collaboration is going. It is a great opportunity for industry to learn from their experience.

    CTC is in its 2nd year and gives the industry a strategic look at how to collaborate in primarily needed outsourced functions to advance drug development. The CTC agenda takes a careful look at three alignment factors: resources, technology and processes along with time, cost, service, and scientific integrity. Depending on the stage of the company and therapeutic area, speakers help guide industry on what to prioritize and how collaborate to fit the need of the organization. For more information, visit: http://theconferenceforum.org/conferences/clinical-trial-collaborations/overview

    Read More

  • March 20, 2017

  • Merck’s Head of Global Clinical Trials, Andy Lee to keynote CTC this April

    Andy Lee, SVP, Head of Global Clinical Trial Operations, Merck, challenged the research team at The Conference Forum to bring a session to CTC (Clinical Trial Collaborations) that speaks to what it really means to truly collaborate for exquisite project delivery. We are delighted to welcome Andy in a keynote discussion with Tufts, Director of […]

    Andy Lee, SVP, Head of Global Clinical Trial Operations, Merck, challenged the research team at The Conference Forum to bring a session to CTC (Clinical Trial Collaborations) that speaks to what it really means to truly collaborate for exquisite project delivery. We are delighted to welcome Andy in a keynote discussion with Tufts, Director of Sponsored Research Programs, Ken Getz as he shares his insights, concerns and suggestions for working more effectively to strike a better balance in the delivery model for effective drug development. Discussion points include:

    • How do companies of different sizes find the model to the get the work done?
    • How do sponsors manage a flexible portfolio; How to best navigate the ups and downs?
    • What’s needed to cover the depth and breadth of projects across the globe?
    • How do you establish partnerships?
    • What is the right model for an organization (fully internal, fully external or a hybrid?)
    • Challenges the CROs have created and their immense capabilities

    Ken Getz will also present at CTC with an industry update on how the clinical collaborations landscape is changing and its impact on R&D operations. Both of these sessions will happen on April 3rd at CTC.

    CTC is in its 2nd year and gives the industry a strategic look at how to collaborate in primarily needed outsourced functions to advance drug development. The CTC agenda takes a careful look at three alignment factors: resources, technology and processes along with time, cost, service, and scientific integrity. Depending on the stage of the company and therapeutic area, speakers help guide industry on what to prioritize and how collaborate to fit the need of the organization. For more information, visit: http://theconferenceforum.org/conferences/clinical-trial-collaborations/overview

    Read More

  • March 16, 2017

  • Clinical Trial Collaborations Press Release

    The 2nd annual Clinical Trial Collaborations event will take place in Boston on April 3-4, 2017 New York, New York, March 16, 2017 – The Conference Forum has announced the launch of the 2nd annual Clinical Trial Collaborations (CTC) conference in Boston on April 3-4, 2017. Led by Co-Chair Katherine Vandebelt, Global Head of Clinical […]

    The 2nd annual Clinical Trial Collaborations event will take place in Boston on April 3-4, 2017

    New York, New York, March 16, 2017 – The Conference Forum has announced the launch of the 2nd annual Clinical Trial Collaborations (CTC) conference in Boston on April 3-4, 2017.

    Led by Co-Chair Katherine Vandebelt, Global Head of Clinical Innovation at Eli Lilly, the CTC conference is the only strategic-level event in the US entirely focused on collaborations needed for 21st Century drug development.

    Valerie Bowling, Executive Director of the CTC event, said, “The future of collaborations in drug development will require partners we never thought of before and new models for outstanding project delivery.”

    The CTC conference offers a variety of sessions that illustrate new collaboration techniques to drive improved clinical trial outcomes and bring clinical trial professionals closer to patients. Ken Getz, Director of Sponsored Research Programs at Tufts CSDD, will kick off the event with a presentation titled, “How the Clinical Collaborations Landscape Is Changing and Its Impact on R&D Operations.” The CTC conference also will feature three first-time keynote presentations:

    Takeda on their Transformational Clinical Development and Marketed Product Partnership with PRA Health Sciences with Dr Andy Plump, Director, Chief Medical and Scientific Officer, Takeda

    Models for Exquisite Project Delivery with Internal and External Partners with Dr Andy Lee, Senior Vice President, Head of Global Clinical Trial Operations, Merck

    Big Trends Impacting Clinical Development with Dr Steve Cutler, Chief Operating Officer and CEO Designate, ICON

    In addition, the CTC conference will feature:

    • Technology Needs and Solutions Discussion: Judith Dunn, Vice President, Global Head of Clinical Development and Head of Innovation Center at Roche, will lead an interactive session on identifying technology needs and solutions.
    • Partnering Tool: All conference attendees can access a partnering tool and partnering facilities to host small group and one-on-one meetings.
    • Clinical Research as a Care Option: This collaborative session scheduled for the entire afternoon of April 4 shows us how clinical trial professionals can bring patients closer to clinical research and can find ways to make clinical trials a care option. It is considered one of the biggest topics for the future of healthcare. Dr John McConnell, CEO, Wake Forest University Medical, is confirmed to keynote this section of the conference.

    The CTC conference offers presentations that deliver insightful clinical trial ideas and challenges for R&D operations, contract resource organizations (CROs) and site executives. It serves as an ideal event for senior-level clinical operation executives from large, medium and small pharmas, CROs, sites and patient advocacy organizations.

    The CTC event is proud to have CenterWatch as its exclusive lead media partner. CenterWatch is the leading source of clinical trial information for both clinical research professionals and patients. For more information about CenterWatch, click here.

    To find more about the CTC conference, click here.

    About The Conference Forum
    The Conference Forum is a drug development industry research firm and presents specialized events for professionals in the life science and healthcare industries. The company currently offer conferences for R&D leaders, clinical development professionals, biotech executives, VCs, drug delivery specialists, patient advocates and FDA executives. The Conference Forum’s mission is to create the best content, exchange ideas and provide quality networking to help move therapeutics to patients faster. To learn more about The Conference Forum, click here.

    Read More

  • January 20, 2017

  • 2nd annual Clinical Trial Collaborations Launches

    2017 Clinical Trial Collaborations Conference: Here’s What You Need to Know Want to find out how to foster collaboration to deliver improved clinical trial outcomes? Check out the 2nd annual Clinical Trial Collaborations (CTC) conference in Boston on April 3 and 4. Led by Co-Chair Katherine Vandebelt, Global Head of Clinical Innovation at Eli Lilly, […]

    2017 Clinical Trial Collaborations Conference: Here’s What You Need to Know

    Want to find out how to foster collaboration to deliver improved clinical trial outcomes? Check out the 2nd annual Clinical Trial Collaborations (CTC) conference in Boston on April 3 and 4.

    Katherine_Vandebelt_bw

    Led by Co-Chair Katherine Vandebelt, Global Head of Clinical Innovation at Eli Lilly, the 2017 CTC conference offers a can’t-miss event for senior-level clinical operation executives at a variety of organizations, including:

    ● Large, medium and small pharmas

    ● Contract resource organizations (CROs)

    ● Sites

     Patient advocacy organizations

    Ultimately, there are many reasons to attend this year’s CTC conference, including:

    1. Kick-Off Presentation from Ken Getz

    ken-getz-2017-bwKen Getz, Director of Sponsored Research Programs at Tufts CSDD, will kick off the CTC conference with a presentation titled, “How the Clinical Collaborations Landscape Is Changing and Its Impact on R&D Operations.”

    The opening presentation will deliver insightful clinical trial ideas and challenges. As such, attendees will be able to gain outstanding insights into a number of key clinical trial topics.

    1. Keynote Presentations

    The CTC 2017 conference will feature three keynote presentations:

    Models for Exquisite Project Delivery with Internal and External Partners

    Andy_Lee_bw

     

    Dr Andy Lee, Senior Vice President, Head of Global Clinical Trial Operations, Merck

     

    Takeda on their Transformational Clinical Development and Marketed Product Partnership with PRA Health Sciences

    Andrew_Plump_bw

     

    Dr Andy Plump, Director, Chief Medical & Scientific Officer, Takeda

     

    Big Trends Impacting Clinical Development

    Steve Cutler B&W

     

    Dr Steve Cutler, Chief Operating Officer and CEO Designate, ICON

     

    In addition, Judith Dunn, Vice President, Global Head of Clinical Development and Head of Innovation Center at Roche will join with Dr Amir Kalalai, VP, QuintilesIMS will lead an interactive session on identifying technology needs and solutions.

    1. Clinical Research as a Care Option

    Clinical Research as a Care Option will require a complex collaboration, but arguably the best way to bring patients closer to clinical research and clinical research closer to patients. The entire afternoon of day two is dedicated to understanding how to work through the process in this unprecedented session.

    1. Partnering Tool

    CTC conference attendees can enjoy enhanced networking opportunities with the event’s partnering tool.

    All conference attendees can access a partnering tool and partnering facilities to host small group and one-on-one meetings. That way, attendees can collaborate with one another and lay the foundation for long-lasting partnerships.

     

    The second annual event takes place at the Renaissance Boston Waterfront hotel. CenterWatch is the exclusive lead media partner and for full details about the CTC conference, click here.

    Take advantage of the launch rate discount of 20% with code ELCTC until January 27, 2017.

    Read More

  • May 13, 2016

  • PharmaTalk Radio Looks at Puerto Rico as an Option for Clinical Trials

    PharmaTalk Radio producer, Valerie Bowling welcomed Dr Myrto Lee, Director, PwC’s Strategy&, UK and Dr Kosmas Kretsos, Executive Director of the Puerto Rico Consortium for Clinical Investigation to learn about key initiatives and outcomes so far to make running clinical trials more attractive in Puerto Rico. They discussed  the quality, capacity and efficiency of running […]

    PharmaTalk Radio producer, Valerie Bowling welcomed Dr Myrto Lee, Director, PwC’s Strategy&, UK and Dr Kosmas Kretsos, Executive Director of the Puerto Rico Consortium for Clinical Investigation to learn about key initiatives and outcomes so far to make running clinical trials more attractive in Puerto Rico. They discussed  the quality, capacity and efficiency of running clinical trials in Puerto Rico along with:

    • Why consider Puerto Rico for clinical trials?
    • Status of new sites to expand clinical trial networks
    • Status of a central coordinator with sites to reduce bureaucracy e.g. central IRB, central invoicing
    • Patient access and costs
    • Access to new technologies
    • Training

    Click here for the program.

     

    For more information about conducting clinical trials in Puerto Rico, please visit www.PRCCI.org.

    Read More

  • April 12, 2016

  • Conference Forum Speaker, Ken Getz quoted in WSJ on the Challenges of Patient Recruitment

    Conference Forum Speaker, Ken Getz, Tufts CSDD quoted in the Wall Street Journal article on the challenges of patient recruitment and the longstanding issue of excessively expensive clinical trials. From the WSJ: Researchers conduct clinical trials to test new drugs and medical treatments, but the rate at which they are able to recruit and retain […]

    Conference Forum Speaker, Ken Getz, Tufts CSDD quoted in the Wall Street Journal article on the challenges of patient recruitment and the longstanding issue of excessively expensive clinical trials.

    Jamie Macdonald and Kenneth Getz at Patients

    Jamie Macdonald, INC Research (Left) with Kenneth Getz, Tufts CSDD (Right) at the Patients as Partners in Clinical Research Conference

    From the WSJ:

    Researchers conduct clinical trials to test new drugs and medical treatments, but the rate at which they are able to recruit and retain patients is at an all-time low.

    Studies indicate that fewer than 10% of Americans participate in clinical trials, and only 3% to 5% of patients sign up for trials of new cancer therapies. Patients often aren’t aware that trials are an option, and their doctors may not suggest them.

    Some patients mistrust the research process and fear being a guinea pig, but for patients who do want to volunteer, complicated protocols and eligibility requirements can be discouraging. About 40% of clinical trials don’t recruit enough patients to meet their goals.

    “The challenges of identifying, recruiting and retaining volunteers for clinical trials drive up the direct and indirect costs of drug development and significantly delay the introduction of new medical interventions,” says Ken Getz, an associate professor at Tufts University School of Medicine’s Center for the Study of Drug Development and board chair of the nonprofit Center for Information & Study on Clinical Research Participation.

    Read the rest of the article here: http://www.wsj.com/articles/clinical-trials-need-more-subjects-1460407076

    Ken will be speaking at the upcoming Chef Medical Officer Summit East (May 11-12, 2016, Boston).

    Read More

  • February 16, 2016

  • Clinical Trial Collaborations: What Needs to Change Now to Prepare for the Future of the Clinical Research Enterprise

    Clinical Trial Collaborations focuses on the future of clinical collaborations, research and outsourcing BOSTON–(BUSINESS WIRE)–Clinical Trial Collaborations, presented by CenterWatch and The Conference Forum, is focused on finding strategic solutions in clinical outsourcing to drive more efficient R&D operations. Impactful insights on the current clinical trials environment will be presented as we ask the big […]

    Clinical Trial Collaborations focuses on the future of clinical collaborations, research and outsourcing

    BOSTON–(BUSINESS WIRE)–Clinical Trial Collaborations, presented by CenterWatch and The Conference Forum, is focused on finding strategic solutions in clinical outsourcing to drive more efficient R&D operations. Impactful insights on the current clinical trials environment will be presented as we ask the big questions on what needs to change now to prepare for the future demands of science, patient needs, new technologies and access to data as well as the changing landscape of R&D infrastructure in both the pharmaceutical and biotech industries. An impressive speaking faculty will share powerful ideas and challenges for R&D operations, CRO and site executives to find new ways to collaborate today and in the next several years.

    Co-chaired by Ken Getz, Director, Sponsored Research Programs Tufts CSDD, the program opens with a keynote on, “How the Drug Development Landscape is Changing and the Impact on R&D Operations.” Robert M. Califf, MD, MACC, Deputy Commissioner for Medical Products and Tobacco, FDA, is a confirmed keynote speaker who will present on the FDA 2016 goals and challenges. Quintiles’ CEO, Tom Pike, will provide insights and advice to pharma on addressing global R&D operation realities and how sponsors can better leverage their CRO. Komathi Stem, Strategic Innovation Leader, Genentech/Roche will address the call for greater collaborations between clinical research and clinical care.

    The Boston Marriott Cambridge Hotel, in the heart of Kendall Square, is hosting this one-of-a-kind strategic level clinical outsourcing event on March 21-22, 2016.

    Read More

  • December 8, 2015

  • Making Clinical Trials a Care Option for Patients on PharmaTalk Radio

    At Dpharm US 2015, Katherine Vandebelt, Global Head, Clinical Innovation, Eli Lilly hosted a talk show on Making Clinical Trials a Care Option for Patients to fantastic reviews. Dpharm Director, Valerie Bowling, welcomes Katherine as she hosts a similar session on Pharma Talk Radio. Katherine (Kathy) discusses how an organized multispecialty healthcare system, clinical research […]

    Katherine

    Katherine Vandebelt, Global Head, Clinical Innovation, Eli Lilly at DPharm US

    At Dpharm US 2015, Katherine Vandebelt, Global Head, Clinical Innovation, Eli Lilly hosted a talk show on Making Clinical Trials a Care Option for Patients to fantastic reviews. Dpharm Director, Valerie Bowling, welcomes Katherine as she hosts a similar session on Pharma Talk Radio. Katherine (Kathy) discusses how an organized multispecialty healthcare system, clinical research site network and pharma company used clinical research as a tool and connector to help improve patient engagement in their overall healthcare management and compliance.

    More specifically:

    – Healthcare System: improving health and service to patients and advocators of clinical research participation

    – Clinical Research Site Network: bringing the right patients to the right trials with increased quality of data and engagement of patients

    – Pharma: expanding our reach to patients and getting trials done faster

    – Shifting the paradigm: Applying a Value Based Health Care Delivery Framework to improve outcomes and reduce healthcare costs

    Panelists

    Panelists at DPharm US

    Radio Show Participants:

    – Host: Katherine Vandebelt, Global Head, Clinical Innovation, Eli Lilly and Company

    – Jeff James, MBA, CEO, Wilmington Health

    – Jennifer Byrne, CEO, PMG Research

    – Allen Buechler, MBA, Advisor, Strategy and Operations, Eli Lilly and Company

    – Toyin Okanlawon, MD, MPH, Senior Health Care Researcher, Harvard Business School Health Care Team


    Click Here to Listen to the Show


     

    Upcoming Clinical Research/Trial Conferences:

    DPharm Europe Logo NewDpharm: Disruptive Clinical Trials Europe, February 9-10, 2016, London, UK

    PatientsAsPartnersLogoPatients as Partners, March 14-15, 2016, Philadelphia, PA

    Collaborations logo 210 x 62 new
    Clinical Trial Collaborations, March 21-22, 2016, Boston, MA

    For information, visit www.theconferenceforum.org

    Read More

  • December 3, 2015

  • Robert M. Califf, MD, MACC is Confirmed to Keynote at the Launch of Clinical Trial Collaborations

    We are delighted to announce that Robert M. Califf, MD, MACC, Deputy Commissioner for Medical Products and Tobacco for the FDA is confirmed to keynote at Clinical Trials Collaborations on March 22nd in Boston, MA. Dr Califf will provide insights into the vision, goals and challenges for the FDA in 2016 as well as provide […]

    We are delighted to announce that Robert M. Califf, MD, MACC, Deputy Commissioner for Medical Products and Tobacco for the FDA is confirmed to keynote at Clinical Trials Collaborations on March 22nd in Boston, MA. Dr Califf will provide insights into the vision, goals and challenges for the FDA in 2016 as well as provide thoughts on the outsourcing environment and what industry can do to help.

    Clinical Trial Collaborations is presented jointly for the first time by Centerwatch and the Conference Forum. The Summit is chaired by Ken Getz, Director, Sponsored Research Programs at Tufts CSDD and provides a truly strategic level event on clinical outsourcing and the future of collaborations to drive more efficient R&D operations. The conference presents powerful ideas for R&D operations, CRO and Site executives to find new ways to collaborate.

    Clinical Trial Collaborations will be held at the Boston Marriott Cambridge Hotel on March 21-21, 2016 in Cambridge, MA. In the spirit of the biopharma boom and intellectual power between Harvard and MIT, Cambridge seemed the logical choice for a clinical operations conference.

    About Robert M. Califf, MD, MACC

    UPDATED_Califf photoRobert M. Califf, MD, MACC, was named Deputy Commissioner for Medical Products and Tobacco for the Food and Drug Administration (FDA) in February of 2015. Dr. Califf provides executive leadership to the Center for Drug Evaluation and Research, the Center for Biologics Evaluation and Research, the Center for Devices and Radiological Health, and the Center for Tobacco Products. He also oversees the Office of Special Medical Programs and provides direction for cross-cutting clinical, scientific, and regulatory initiatives, including precision medicine, combination products, orphan drugs, pediatric therapeutics, and the advisory committee system.

    Prior to joining the FDA, Dr. Califf was a professor of medicine and vice chancellor for clinical and translational research at Duke University. He also served as director of the Duke Translational Medicine Institute and founding director of the Duke Clinical Research Institute. A nationally and internationally recognized expert in cardiovascular medicine, health outcomes research, healthcare quality, and clinical research, Dr. Califf has led many landmark clinical trials and is one of the most frequently cited authors in biomedical science, with more than 1,200 publications in the peer-reviewed literature.

    Dr. Califf has served on the Institute of Medicine (IOM) committees that recommended Medicare coverage of clinical trials and the removal of ephedra from the market, as well as on the IOM Committee on Identifying and Preventing Medication Errors and the IOM Health Sciences Policy Board. He has served as a member of the FDA Cardiorenal Advisory Panel and FDA Science Board’s Subcommittee on Science and Technology. Dr. Califf has also served on the Board of Scientific Counselors for the National Institutes of Health and the National Library of Medicine, as well as on advisory committees for the National Cancer Institute, the National Heart, Lung, and Blood Institute, the National Institute of Environmental Health Sciences and the Council of the National Institute on Aging.

    While at Duke, Dr. Califf led major initiatives aimed at improving methods and infrastructure for clinical research, including the Clinical Trials Transformation Initiative (CTTI), a public-private partnership co-founded by the FDA and Duke. He also served as the principal investigator for Duke’s Clinical and Translational Science Award and the NIH Health Care Systems Research Collaboratory coordinating center.

    Dr. Califf is a graduate of Duke University School of Medicine. He completed a residency in internal medicine at the University of California, San Francisco and a fellowship in cardiology at Duke.

    About CenterWatch

    CenterWatch logoSince 1994, CenterWatch, has been the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from sponsors and CROs to research sites and niche providers. For more information, visit www.centerwatch.com.

    About The Conference Forum

    conference-forumThe Conference Forum has a very specific focus – developing specialized events, both public and private as well as research groups and advisory boards, for professionals in the life science and healthcare industries. Their mission is to create the best content, exchange ideas and solutions among peers and provide quality networking for Pharmaceutical and Biotech professionals. For more information, visit http://theconferenceforum.org.

     

    Read More

  • November 4, 2015

  • The Conference Forum and CenterWatch Collaborate to Present Strategic Level Clinical Outsourcing Event in Cambridge, MA

    Clinical Trial Collaborations focuses on strategic solutions in clinical outsourcing to drive more efficient R&D operations. The Conference Forum, a specialized life science research and conference development firm, today announced their collaboration with CenterWatch, a leading publisher of clinical trials information. Together they are presenting the first summit chaired by Ken Getz, Director, Sponsored Research […]

    Clinical Trial Collaborations focuses on strategic solutions in clinical outsourcing to drive more efficient R&D operations.

    The Conference Forum, a specialized life science research and conference development firm, today announced their collaboration with CenterWatch, a leading publisher of clinical trials information. Together they are presenting the first summit chaired by Ken Getz, Director, Sponsored Research Programs at Tufts CSDD that provides a truly strategic level event on clinical outsourcing and the future of collaborations to drive more efficient R&D operations.

    The conference, Clinical Trial Collaborations, presents powerful ideas and challenges for R&D operations, CRO and Site executives to find new ways to collaborate.

    Clinical Trial Collaborations will be held at the Boston Marriott Cambridge Hotel on March 21 and 22, 2016, in the heart of Kendall Square in Cambridge, MA. In the spirit of the biopharma boom and intellectual power between Harvard and MIT, Cambridge seemed the logical choice for a strategic level clinical outsourcing conference.

    About CenterWatch
    Since 1994, CenterWatch, has been the recognized global leader in providing clinical trials information to a broad and influential spectrum of clinical research professionals ranging from sponsors and CROs to research sites and niche providers. For more information, visit www.centerwatch.com.

    About The Conference Forum
    The Conference Forum has a very specific focus – developing specialized events, both public and private as well as research groups and advisory boards, for professionals in the life science and healthcare industries. Our mission is to create the best content, exchange ideas and solutions among peers and provide quality networking for Pharmaceutical and Biotech professionals. For more information, visit http://theconferenceforum.org.

    Read More